Salta al contenuto principale
Passa alla visualizzazione normale.


Pari opportunità

Ricerca avanzata per:

Risultati della ricerca

  • 121. albodottori2010-2011 (15%)

    25-lug-2017 12.19.00

  • 122. Trials Clinici 2008-2018 (15%)

    27-mag-2022 13.18.01

    : Fulvestrant and Everolimus plus Exemestane in metastatic breast cancer GIM16-Fevex Delibera N° 1047

  • 123. Relazione AQ Dipartimento BiND (15%)

    11-ott-2023 9.29.14

  • 124. Relazione AQ Dipartimento BiND su settori critici - 31 luglio 2023 (15%)

    30-nov-2023 13.03.10

  • 125. Verbale riunione telematica 31 luglio 2023 - relazione delibera CdA 04.01 del 19 maggio 2023 (15%)

    30-nov-2023 13.03.11

  • 126. Pubblicazioni STeBiCeF 2020 (15%)

    1-dic-2023 8.29.02

    and AKT, regulates cell fate of MDA-MB-231 triple- 10447/363247 10.1002/jcp.29062 negative breast ... Species Production and Autophagic Activity in Triple-Negative MDA-MB231 Breast Cancer Cells

  • 127. Pubblicazioni STeBiCeF 2021 (15%)

    1-dic-2023 8.29.02

    on MCF-7 Breast Cancer Cells. INTERNATIONAL JOURNAL OF 10447/495272 10.3390/ijms22073410 MOLECULAR ... of Heat Shock Proteins (HSPs) in Breast Cancer Unveiled by Multi-Omics Approaches. BIOLOGY, 10(3), 1-26 ... . (2021). Marine Animal-Derived Compounds and Autophagy Modulation in Breast Cancer Cells 10447

  • 128. Pubblicazioni STeBiCeF 2022 (15%)

    1-dic-2023 8.29.02

    effect in triple‐negative breast cancer cells. 10447/562818 10.3892/mmr.2022.12759 MOLECULAR

  • 129. l1-cv-gulotta (15%)

    16-apr-2020 10.35.01

    testing in 106 breast and ovarian cancer families from southern Italy: a mutation analyses Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful

  • 130. Prot. 5351 del 06.08.2020_Relazione MV RAIMONDI (15%)

    17-set-2020 14.11.08

    . The Fibroblast Growth Factor Receptors in Breast Cancer: From Oncogenesis to Better Treatments. Int J Mol Sci ... Enhance Breast Cancer Cells Survival. Oncotarget 2016, 7 (36), 57633–57650. https://doi.org/10.18632

  • 131. Lab. Genetica ed Oncologia Molecolare Clinica - Prof. A. Russo (15%)

    5-giu-2013 21.02.33

     expression  in breast cancer cells: role of hypoxia‐inducible  factor‐ 1alpha. ONCOGENE. pp. 1‐8 ...  expression of leptin and the leptin receptor as a  marker of breast cancer progression: possible role

  • 132. Lab. Tecnologie oncologiche -Prof. Lunghi (15%)

    5-giu-2013 21.06.09

    Integrated Approach to Study Breast Cancer: Differences in Patients negative and Positive to 18F-FDG PET ... transition in a breast cancer primary culture: a study report. BMC Research Notes, 2012; 5 (1): 343 (Epub

  • 133. Public engagement 2016 (15%)

    17-nov-2020 20.26.49

    , e con l’organizzazione annuale del Bray-Day Breast reconstruction Awareness iniziativa “Incontri con la Ricerca ... ; l’organizzazione della Giornata AIRC, e con l’organizzazione annuale del Bray-Day Breast reconstruction

  • 134. programma RBB 2014 (15%)

    25-giu-2014 9.54.06

    parthenolide on triple negative breast cancer cells. 14.50 – 15.10 Gaetano Felice Caldara ... A proteomic signature for breast cancer patients stratification 12.10 – 12.30 Loredana Randazzo

  • 135. commissone bs 143-2022 todaro (15%)

    12-set-2022 9.03.26

    to phenotype for breast and colorectalcancerstemcells: implications and perspectives in cancer therapy ... for breast and colorectalcancerstemcells: implications and perspectives in cancer therapy”; Responsabile

  • 136. Seminario (15%)

    13-mar-2023 11.58.48

    Seminario articolo, notizia, unipa SEMINARIO: Giovedì 16 Marzo 2023 - ore 15:30, Aula Vincenzo Mutolo - Dipartimento STEBICEF, Prof. Antonino B. D’Assoro Associate Professor of Pharmacology Medical Oncology, Mayo Clinic Rochester, USA. “ Role of Aurora-A Mitotic Kinase in Breast Cancer: From the Bench to the Bedside" Locandina MASSIMO MARCO SEMINARIO: Giovedì 16 Marzo 2023 - ore 15:30, Aula ... of Pharmacology Medical Oncology, Mayo Clinic Rochester, USA. “ Role of Aurora-A Mitotic Kinase in Breast

  • 137. Verbale_Commissione-AQRD_2023-10-16 (15%)

    17-ott-2023 9.53.13

    Stem Cells. ACS Appl. Polym. Mater. Q1 IF 5.0 Effective targeting of breast cancer stem cells ... Preclinico: Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51

  • 138. Dottorandi XXXVIII Ciclo (15%)

    9-mar-2023 9.23.58

    for morbidity reduction in breast oncologic surgery: a single-center interventional study in patients undergoing mastectomy, sentinel lymph node biopsy or axillary lymph node dissection and simultaneous breast

  • 139. Progetti Dottorato di ricerca XXIX ciclo (concluso) (15%)

    11-nov-2021 9.00.04

    in triple negative breast cancer phenotype Co.Co.Pro come biotecnologo industriale, progetto “Promozione ... chirurgico" Curriculum Vitae Tesi di dottorato Breast cancer related lymphedema: definition

  • 140. Progetti Dottorato di ricerca XXXVIII ciclo (15%)

    20-apr-2023 12.58.44

    for morbidity reduction in breast oncologic surgery: a single-center interventional study in patients undergoing mastectomy, sentinel lymph node biopsy or axillary lymph node dissection and simultaneous breast